Radiotherapy effects on anti-tumor immunity: Implications for cancer treatment

Frontiers in Oncology

Volumn 3 MAY, Issue , 2013, Pages

  Demaria, Sandra ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE;

CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DEATH; DENDRITIC CELL; EDITORIAL; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; IONIZING RADIATION; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 84885799432     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00128     Document Type: Editorial

References (9)

1. Burnette, B., Fu, Y. X., and Weichselbaum, R. R. (2012). The confluence of radiotherapy and immunotherapy. Front. Oncol. 2:143. doi: 10.3389/fonc.2012.00143
2. Chiang, C. S., Fu, S. Y., Wang, S. C., Yu, C. F., Chen, F. H., Lin, C. M., et al. (2012). Irradiation promotes an M2 macrophage phenotype in tumor hypoxia. Front. Oncol. 2:89. doi: 10.3389/fonc.2012.00089
3. Demaria, S., and Formenti, S. C. (2012). Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front. Oncol. 2:153. doi: 10.3389/fonc.2012.00153
4. Finkelstein, S. E., and Fishman, M. (2012). Clinical opportunities in combining immunotherapy with radiation therapy. Front. Oncol. 2:169. doi: 10.3389/fonc.2012.00169
5. Golden, E. B., Pellicciotta, I., Demaria, S., Barcellos-Hoff, M. H., and Formenti, S. C. (2012). The convergence of radiation and immunogenic cell death signaling pathways. Front. Oncol. 2:88. doi: 10.3389/fonc.2012.00088
6. Kwilas, A. R., Donahue, R. N., Bernstein, M. B., and Hodge, J. W. (2012). In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer. Front. Oncol. 2:104. doi: 10.3389/fonc.2012.00104
7. Mason, K. A., and Hunter, N. R. (2012). CpG plus radiotherapy: a review of preclinical works leading to clinical trial. Front. Oncol. 2:101. doi: 10.3389/fonc.2012.00101
8. Schaue, D., Xie, M. W., Ratikan, J. A., and McBride, W. H. (2012). Regulatory T cells in radiotherapeutic responses. Front. Oncol. 2:90. doi: 10.3389/fonc.2012.00090
9. Vanpouille-Box, C., and Hindré, F. (2012). Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front. Oncol. 2:136. doi: 10.3389/fonc.2012.00090